Triastek, Inc.’s Post

How will 3D printing transform pharmaceutical manufacturing? Have a look at my recent discussion with David Alvaro from Pharma's Almanac. #pharma #manufacturing #additivemanufacturing #3Dprinting

In this new Q&A on Pharma's Almanac, MilliporeSigma’s Thomas Kipping, sheds light on the evolution, current state, and future prospects of 3D printing in pharma, including applications for creating innovative dosage forms and streamlining the supply of clinical trial material. #pharma #3dprinting #additivemanufacturing #clinicalsupply #osd #pharmaceuticalinnovation

This #WorldHealthDay, we’re getting personal(ized) 💊    The theme for this year’s global celebration of all things healthcare is #MyHealthMyRight, and what is a better expression of this than the hot topic of personalized, 3D-printed medications?    By allowing customization down to each individual tablet layer, this technology cuts through the traditional “one size fits all” to offer patients highly specific, highly effective treatments – no matter how rare their complaint.     Most 3D-printed pharmaceuticals are currently produced using a combination of fusion deposition modeling (FDM) and synthetic oil-based materials, but could plant-based excipients offer a safer, more sustainable alternative?    Discover the answer in our exclusive case study dedicated to determining whether modified starches could help kick-start a new phase in 3D printing, fit to meet the needs of empowered patients worldwide.    Read the study now: https://lnkd.in/gFjrxebw     #WHD2024 #pharmaceuticals #drugdelivery #excipients 

The list of jobs that impress an 8-year-old is very short. However there is one exception: A job involving lasers! 🚀🚀🚀 Thomas Kipping, at least some of the time, uses lasers to make pills. Lasers are one tactic in 3D printing that make it easier to produce a smaller quantity of pills. See how Kipping’s team is making futuristic sounding techniques a reality. #pharma #manufacturing #drugdevelopment #innovation #3Dprinting #laserprinting #SLS

Discover this Q&A, where Thomas Kipping, Ph.D., Head of 3D Printing and Solubility Enhancement, sheds light on the evolution, current state, and future prospects of #3Dprinting in pharma, in conversation with Pharma‘s Almanac to discuss the topic of additive manufacturing, commonly known as 3D printing, and how it is reshaping pharmaceutical manufacturing. Unlike traditional oral solid dose (OSD) manufacturing, 3D printing offers unparalleled flexibility in designing drug prototypes, final dosage forms enabling precision dosing and the creation of complex release kinetics. This technology is especially valuable during early R&D, for creating innovative dosage forms and streamlining the supply of clinical trial material. Our raw materials portfolio plays a leading role in the 3D printing space, establishing collaborations and developing products to realize the potential of additive manufacturing. #solidformulation #formulation #osd #drugdevelopment

3D printing of pharmaceuticals is the future! We are excited to be a part of it..check out this article to hear from our expert Thomas Kipping about this paradigm-shifting technology https://lnkd.in/ebvd5DzR

Discover this Q&A, where Thomas Kipping, Ph.D., Head of 3D Printing and Solubility Enhancement, sheds light on the evolution, current state, and future prospects of 3D printing in pharma, in conversation with Pharma’s Almanac's to discuss the topic of additive manufacturing, commonly known as 3D printing, and how it is reshaping pharmaceutical manufacturing. Unlike traditional oral solid dose (OSD) manufacturing, 3D printing offers unparalleled flexibility in designing drug prototypes, final dosage forms enabling precision dosing and the creation of complex release kinetics. This technology is especially valuable during early R&D, for creating innovative dosage forms and streamlining the supply of clinical trial material. Our raw materials portfolio plays a leading role in the 3D printing space, establishing collaborations and developing products to realize the potential of additive manufacturing. #solidformulation #formulation #osd #drugdevelopment

Discover this Q&A, where Thomas Kipping, Ph.D., Head of 3D Printing and Solubility Enhancement, sheds light on the evolution, current state, and future prospects of 3D printing in pharma, in conversation with Pharma’s Almanac's to discuss the topic of additive manufacturing, commonly known as 3D printing, and how it is reshaping pharmaceutical manufacturing. Unlike traditional oral solid dose (OSD) manufacturing, 3D printing offers unparalleled flexibility in designing drug prototypes, final dosage forms enabling precision dosing and the creation of complex release kinetics. This technology is especially valuable during early R&D, for creating innovative dosage forms and streamlining the supply of clinical trial material. Our raw materials portfolio plays a leading role in the 3D printing space, establishing collaborations and developing products to realize the potential of additive manufacturing. #solidformulation #formulation #osd #drugdevelopment

Discover this Q&A, where Thomas Kipping, Ph.D., Head of 3D Printing and Solubility Enhancement, sheds light on the evolution, current state, and future prospects of 3D printing in pharma, in conversation with Pharma’s Almanac's to discuss the topic of additive manufacturing, commonly known as 3D printing, and how it is reshaping pharmaceutical manufacturing. Unlike traditional oral solid dose (OSD) manufacturing, 3D printing offers unparalleled flexibility in designing drug prototypes, final dosage forms enabling precision dosing and the creation of complex release kinetics. This technology is especially valuable during early R&D, for creating innovative dosage forms and streamlining the supply of clinical trial material. Our raw materials portfolio plays a leading role in the 3D printing space, establishing collaborations and developing products to realize the potential of additive manufacturing. #solidformulation #formulation #osd #drugdevelopment

Innovating the Future of Pharmaceuticals: A New Chapter in 3D Printing and AI Excited to unveil our latest milestone in pharmaceutical innovation: a book chapter titled "3D Printing of Pharmaceutical Products Using AI Technology," published in a prestigious volume accessible here: https://lnkd.in/dP64K8pT. This chapter represents a significant advance in the field, blending AI with 3D Printing (Additive Manufacturing) to redefine what's possible in drug production and personalized medicine. We delve into how this cutting-edge integration overcomes traditional barriers in 3D printing, such as enhancing production speeds, enabling automation, and facilitating the creation of complex, custom-tailored drug formulas. Our collaborative effort sheds light on the untapped potential of AI and Machine Learning to revolutionize pharmaceutical manufacturing, offering a blueprint for future innovations that prioritize efficiency, precision, and patient-specific care. This work not only paves the way for individualized medication solutions but also sets a new standard for the industry, moving us towards a more personalized, patient-centric healthcare model. I have heartfelt gratitude to my co-authors, Anand Kumar S, Dr. Mitali Pareek, Sneha Sharma, and Dr Rajkumar Velu, for their unwavering dedication and profound insights. We are proud to contribute to this transformative journey in healthcare technology. #3DPrinting #AIinPharma #AdditiveManufacturing #PharmaceuticalManufacturing #DigitalHealth #InnovationInHealthcare